Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

Prog Lipid Res

Department of Physiology, University of Tennessee Health Science Center, 71 S. Manassas Street Memphis, Memphis, TN 38163, USA. Electronic address:

Published: January 2019

12/15-lipoxygenase (12/15-LOX) is an enzyme, which oxidizes polyunsaturated fatty acids, particularly omega-6 and -3 fatty acids, to generate a number of bioactive lipid metabolites. A large number of studies have revealed the importance of 12/15-LOX role in oxidative and inflammatory responses. The in vitro studies have demonstrated the ability of 12/15-LOX metabolites in the expression of various genes and production of cytokine related to inflammation and resolution of inflammation. The studies with the use of knockout and transgenic animals for 12/15-LOX have further shown its involvement in the pathogenesis of a variety of human diseases, including cardiovascular, renal, neurological and metabolic disorders. This review summarizes our current knowledge on the role of 12/15-LOX in inflammation and various human diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338518PMC
http://dx.doi.org/10.1016/j.plipres.2018.11.001DOI Listing

Publication Analysis

Top Keywords

fatty acids
8
human diseases
8
12/15-lox
5
emerging role
4
role 12/15-lipoxygenase
4
12/15-lipoxygenase alox15
4
alox15 human
4
human pathologies
4
pathologies 12/15-lipoxygenase
4
12/15-lipoxygenase 12/15-lox
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!